Poor heart health increases risk of dementia for Black Americans
Peer-Reviewed Publication
Updates every hour. Last Updated: 15-Jun-2025 05:09 ET (15-Jun-2025 09:09 GMT/UTC)
Diabetes and hypertension could have a domino effect for future health problems like dementia — especially for Black Americans, according to a new University of Georgia study.
Investigators at the Icahn School of Medicine at Mount Sinai have been named semifinalists—and one of the Top 40 Milestone Award winners—in the prestigious XPRIZE Healthspan, a $101 million global competition dedicated to transforming how we age. XPRIZE Healthspan challenges the world’s top scientists and clinicians to develop treatments that can restore muscle strength, cognitive performance, and immune function in older adults by at least 10 years, with a bold goal of 20 years. Selected from a highly competitive international pool, Mount Sinai’s multidisciplinary team, NYC-Vita, stood out for its innovative, feasible, and safe approach. The team was named a Milestone 1 Awardee in the competition, earning $250,000 in funding to advance to the next phase: a clinical trial to be conducted in New York City.
The Buck Institute for Research on Aging is proud to announce that a team of Buck scientists, in collaboration with colleagues at Hospital-University Institute HealthAge at the University of Toulouse, has been named a semifinalist for the 7-year, $101 million XPRIZE Healthspan. The global competition is intended to revolutionize how we approach human aging. Competing teams are tasked with developing and testing modalities that restore muscle, cognition, and immune function by a minimum of 10 years, with an ambitious goal of 20 years, in persons aged 50-80 years, in one year or less.